Mirabegron Ameliorated Atherosclerosis of ApoE −/− Mice in Chronic Intermittent Hypoxia but Not in Normoxia

ConclusionThis study first demonstrated that mirabegron impeded the progression of CIH-induced atherosclerosis, at least in part, via β3 AR–mediated oxidative stress, suggesting a promising therapeutic strategy for protecting against atherosclerosis induced by CIH.

Source: Cardiovascular Drugs and Therapy - June 21, 2021 Category: Cardiology Source Type: research